BTA
Click for more information
0.00% 57.0¢ biota holdings limited

We just don't see it but GSK are pushing hard to sell Relenza to...

  1. PortableAlpha
    3,045 Posts.
    clock Created with Sketch.
    30/01/10
    21:46
    Post #: 6266270
    We just don't see it but GSK are pushing hard to sell Relenza to stockpilers, and all the evidence on tamiflu resistance will assist their cause. This coming quarterly will homefully confirm what many investors have been anticipating, a large global shift towards Relenza.
    BTA Price at posting: $2.00 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

FMG FMG reports third highest earnings in history on strong iron ore sales
right-arrow Created with Sketch.
EMR Emerald expands underground resource by 105Koz at Cambodian gold mine Okvau
right-arrow Created with Sketch.
TLG Talga expands Prospectus Offer to $9M, banks $18.5M overall since end of financial year
right-arrow Created with Sketch.
NEWS Results wrap: Wesfarmers, Southern Cross Media, Qantas
right-arrow Created with Sketch.
HYT Twiggy Forrest to acquire 40% of native hydrogen explorer – not long after putting Fortescue Future Industries to sleep
right-arrow Created with Sketch.
NEWS Inflation cools in the 12 months to July, on-target reading of 3.5%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.